¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"cis isomer"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
¿µ¹® isomer ÇÑ±Û À̼ºÁúü, À̼ºÃ¼
¼³¸í   
  1. °°Àº ¿øÀÚ ¹øÈ£¿Í Áú·®¼ö¸¦ °¡Áö¸é¼­ ¹Ý°¨±â, ¿¡³ÊÁö »óÅÂ, ¹æ»ç´ÉÀÇ ¼ºÁúÀÌ ´Ù¸¥ ¿øÀÚÇÙ. 2. ºÐÀÚ½ÄÀº °°Áö¸¸ ´Ù¸¥ ¹°¸®Àû-È­ÇÐÀû ¼ºÁúÀ» °®´Â È­ÇÕ¹°. ºÐÀÚ ¾È¿¡¼­ ¿øÀÚÀÇ ¹è¿­ ¹æ½ÄÀÌ ´Ù¸£±â ¶§¹®¿¡ ÀÌ·¯ÇÑ È­ÇÕ¹°ÀÌ »ý±ä´Ù. 
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • isomer
    À̼ºÁúü, À̼ºÃ¼
  • nuclear isomer
    ÇÙÀ̼ºÃ¼
  • optical isomer
    ±¤ÇÐÀ̼ºÃ¼
  • rotation isomer
    ȸÀüÀ̼ºÃ¼
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • isomer
    À̼ºÁúü, À̼ºÃ¼
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • isomer
    À̼ºÁúü, À̼ºÃ¼
  • nuclear isomer
    ÇÙÀ̼ºÃ¼
  • optical isomer
    ±¤ÇÐÀ̼ºÃ¼
  • rotation isomer
    ȸÀüÀ̼ºÃ¼
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 8 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • cis-trans test
    ½Ã½º-Æ®·£½º°Ë»ç
  • isomer
    À̼ºÁúü
  • isomer
    À̼ºÁúü(ì¶àõòõô÷), À̼ºÃ¼.
  • nuclear isomer
    ÇÙÀ̼ºÃ¼
  • nuclear isomer
    ÇÙÀ̼ºÃ¼(ú·ì¶àõô÷).
  • nucleus isomer
    ÇÙÀ̼ºÃ¼(ú·ì¶àõô÷).
  • optical isomer
    ±¤ÇÐÀû À̼ºÃ¼(ÎÃùÊîÜì¶àõô÷).
  • rotation isomer
    ȸÀüÀ̼ºÃ¼(¡­ì¶àõô÷).
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • cis isomer
    ½Ã½º À̼ºÃ¼(ì¶àõô÷)
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • cis-aconitic acid
    ½Ã½º-¾ÆÄÚ´ÏÆ¾»ê (ß«)
  • cis
    ½Ã½º
  • cis-acting locus
    ½Ã½ºÀÛ¿ë ºÎÀ§(íÂéÄÝ»êÈ)
  • cis-dominant
    ½Ã½º ¿ì¼º(éÐàõ)
  • cis effect
    ½Ã½º È¿°ú(üùÍý)
  • cis interactions
    ½Ã½º »óÈ£ÀÛ¿ë(ßÓû»íÂéÄ)
  • cis-trans isomers
    ½Ã½ºÆ®¶õ½º À̼ºÃ¼(ì¶àõô÷)
  • cis-trans test
    ½Ã½ºÆ®¶õ½º ½ÃÇè(ãËúÐ)
  • 11-cis-retinal
    11-½Ã½º ·¹Æ¼³¯
  • chain isomer
    »ç½½À̼ºÃ¼(ì¶àõô÷)
  • conformational isomer
    "ÀÔüÇüÅ À̼ºÃ¼(Ø¡ô÷û¡÷¾ì¶àõô÷), (ÔÒ) conformer"
  • functional group isomer
    ÀÛ¿ë±â(íÂéÄÐñ) À̼ºÃ¼(ì¶àõô÷)
  • geometrical isomer
    ±âÇÏ À̼ºÁúü(Ðúù¼ì¶àõòõô÷)
  • isomer
    ¾ÆÀ̼ҸÓ
  • isomer number
    ¾ÆÀÌ¼Ò¸Ó ¼ö(â¦)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
CAP Cyclophosphamide, Adriamycin(Doxorubicin), cis-Platinum
CIS Carcinoma In Situ
PEV cis-Platinum, Etoposide, Vinblastine
CDDP cis-diaminedichloroplatinum
CIS carcinoma in situ; catheter-induced spasm; central inhibitory state; Chemical Information Service; c...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
13-cis-RA 13 cis retinoic acid
9-cis-RA 9-Cis-retinoic acid
cis-DDP Cis-Dichlorodiammine platinum
Cis-DDP Cis-diaminedichloro-platinum
cis-DDP Cis-diamminedichloroplatinum II
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • cis-trans
    ½Ã½º-Æ®¶õ½º ½ÃÇè
    ¹Ì»ý¹° À¯ÀüÇп¡¼­, µ¿ÀÏÇÑ Ç¥ÇöÇü È¿°ú¸¦ °®´Â µÎ °¡Áö µ¹¿¬º¯À̰¡ µ¿ÀÏÇÑ À¯ÀüÀÚ³»¿¡ Á¸ÀçÇÏ´ÂÁö ¶Ç´Â ´Ù¸¥ À¯ÀüÀÚ¿¡ Á¸ÀçÇÏ´ÂÁö¸¦ ÆÇÁ¤ÇÏ´Â ½ÃÇè.
  • nuclear isomer
    ÇÙ À̼ºÃ¼
  • nucleus isomer
    ÇÙ À̼ºÃ¼
  • optical isomer
    ±¤ÇÐÀû À̼ºÃ¼
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
3-carboxy-cis-cis-muconate cyclase <enzyme> Do not confuse with muconate cycloisomerase
Registry number: EC 5.5.1.5
Synonym: 3-carboxy-cis,cis-muconate lactonizing enzyme, 3-cmle, carboxy-cis,cis-muconate cyclase
(26 Jun 1999)
geometric isomer <chemistry> Geometric or also called cis-trans isomers are stereoisomers in molecules with restricted rotation about a bond.
Cycloalkanes and alkenes form cis-trans isomers due to the restriction of rotation about the double bond or due to the restriction in a ring. In order for an alkene to freely rotate, the pi bond must be broken.
This process has a high activation energy and does not occur at room temperature. Cis isomers have the two substituents on each of the carbons of the double bond on the same side, whereas in the trans isomer they are on opposite sides. The expression cis and trans only applies to alkenes or cycloalkanes if one of the substituents on each of the carbons are the same. If there are three or four different substituents, E,Z or R,S nomenclature must be used.
(09 Jan 1998)
chain isomer <chemistry> One of two or more compounds having the same chemical composition but differing in the arrangement of the atoms (usually carbon atoms) forming the backbone of the structure of the compounds.
(21 Mar 1998)
dextrorotatory isomer A stereoisomer that does a clockwise rotation of plane-polarized light.
(09 Oct 1997)
isomer 1. <chemistry> One of two or more molecules that have the same chemical formula but have a different stereochemical arrangement of their atoms.
2. <radiobiology> Nuclides having the same number of neutrons and protons but capable of existing, for a measurable time, in different quantum states with different energies and radioactive properties. Commonly, the isomer of higher energy decays to one of lower energy by the process of isomeric transition.
(13 Nov 1997)
levorotatory isomer A stereoisomer that rotates the plane of polarized light counterclockwise.
(09 Oct 1997)
peptidyl prolyl cis trans isomerase See: PPIase and immunophilin.
(18 Nov 1997)
CIS <abbreviation> Carcinoma in situ.
(05 Mar 2000)
cis- 1. <prefix> Prefix meaning on this side, on the near side; opposite of trans-.
2. <genetics> A prefix denoting the location of two or more genes on the same chromosome of a homologous pair, in coupling.
3. <chemistry> A form of geometric isomerism in which similar functional groups are attached on the same side of the plane that includes two adjacent, fixed carbon atoms (e.g., the 2-and 3-OH groups of ribofuranose) in a ring structure. Identical functional groups on the same side of the double bond are cis-. When the four moieties attached to the carbons of the double bond are all different, then the E/Z nomenclature has to be followed.
See: entgegen, zusammen.
Origin: L.
(20 Jun 2000)
cis-1,2-dihydrobenzene-1,2-diol dehydrogenase <enzyme> See also EC 1.3.1.20 (trans-1,2-dihydrobenzene-1,2-diol dehydrogenase; both enzymes catalyze the conversion of benzene dihydrodiol to catechol and may also have hydroxysteroid dehydrogenase activity
Chemical name: cis-1,2-dihydroxycyclohexa-3,5-diene (nad) oxidoreductase
Registry number: EC 1.3.1.19
Synonym: cis-benzene glycol dehydrogenase, cis-diol dehydrogenase, benzene dihydrodiol dehydrogenase, bedd gene product, nad+-dependent cis-benzene dihydrodiol dehydrogenase, todd gene product
(26 Jun 1999)
cis-3-chloroacrylic acid dehalogenase <enzyme> Specific for conversion of cis-3-chloroacrylic acid to muconic saemialdehyde (3-oxopropionic acid); 48 amino-terminal amino acid sequence given in first source
Registry number: EC 3.8.1.-
Synonym: cis-3caa dehalogenase
(26 Jun 1999)
cis-9,trans-11-octadecadienoate reductase <enzyme> Uses NADH and alpha-tocopherol quinol; forms trans-11-octadecenoate
Registry number: EC 1.3.1.-
Synonym: 9,11-ocdd reductase
(26 Jun 1999)
cis-aconitic acid Dehydration product of citric acid; an enzyme-bound intermediate in the tricarboxylic acid cycle.
(05 Mar 2000)
cis acting <molecular biology> Having to do with a genetic element (such as a promoter or other regulatory locus) having an effect (like promotion or suppression) on two unrelated targets (such as genes) on the same chromosome as a result of their relative positions on the chromosome.
A gene which regulates the transcription into mRNA of other genes nearby on the same chromosome by binding protein transcription factors which are necessary to turn transcription on or off.
(09 Oct 1997)
cis-acting locus A section of DNA that affects the activity of DNA sequences on that same molecule of DNA.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Isomer
    (È­)(µ¿Áú)À̼ºÃ¼
  • CIS
    Chemical Information System;communication interface system;Counter intelligence Service ´ë øº¸ºÎ
  • cis-
    ...ÀÇ ÀÌÂÊÀÇ ¶æ
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á